Related Experiment Video
Updated: May 26, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Intrinsic curvature in duplex DNA inhibits Human Topoisomerase I
Zhaoqi Yang1, Dawei Li, Juanjuan Guo
1Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, 21 Nanyang Link, Nanyang Technological University, Singapore 637371, Singapore.
Abstract:
Human Topoisomerase I (hTopo I) have been known as a potential target for cancer therapy. A series of duplex DNA with different intrinsic curvatures have been designed as inhibitors to hTopo I. The activities of hTopo I on relaxing supercoiled plasmid pUC 19 are apparently diminished in the presence of the curved DNA. More potent inhibitions and smaller IC(50) are achieved by duplex DNA with higher curvatures. EMSA indicates that hTopo I can recognize the curved DNA through binding interactions. Our studies demonstrate that the activity of hTopo I can be modulated by the intrinsic curvature of linear DNA and provide a new avenue to design curved DNA as hTopo I inhibitors with high therapeutic efficiency and low toxicity.
Insights
Curved DNA effectively inhibits human topoisomerase I (hTopo I), a key target in cancer therapy. Higher DNA curvature leads to more potent inhibition, offering a novel therapeutic strategy with reduced toxicity.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- Human topoisomerase I (hTopo I) is a validated target for anti-cancer drug development.
- Developing novel inhibitors with improved efficacy and reduced toxicity is crucial for cancer therapy.
Purpose of the Study:
- To investigate the potential of intrinsically curved DNA as inhibitors of human topoisomerase I.
- To explore the relationship between DNA curvature and inhibitory potency against hTopo I.
Main Methods:
- Design and synthesis of duplex DNA molecules with varying intrinsic curvatures.
- Assay of hTopo I activity in the presence of designed DNA molecules.
- Electrophoretic Mobility Shift Assay (EMSA) to study DNA-protein interactions.
Main Results:
- Curved DNA significantly diminished the supercoil relaxation activity of hTopo I.
- Increased DNA curvature correlated with more potent inhibition and lower IC(50) values.
- EMSA confirmed direct binding interactions between hTopo I and curved DNA.
Conclusions:
- The intrinsic curvature of linear DNA can modulate hTopo I activity.
- Curved DNA represents a promising new class of hTopo I inhibitors for cancer therapy.
- This approach offers potential for high therapeutic efficiency and low toxicity.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Inhibitors of Bacterial DNA Synthesis
Single-Strand DNA Binding Proteins
Restarting Stalled Replication Forks
DNA Helicases
The DNA Replication Fork

